We are celebrating 23 years in Business - Thank You For Making Us The #1 Go To Site for Your Health Care

hematology, medical oncology, oncology review course, board review, recalled oncology questions, breast cancer, radiation, bone, cervix, breast, lymphoma, oncology, pediatrics, breast surgery, colon, hydrotherapy, prostate, prostate cancer, oncology board review questions, bladder, bone tumors, bladder, wilms tumor, hematology, colon, testicular, radiation therapy, radiation treatment, colon cancer, skin, carcinoma, endometrium, bone marrow, bone cancer, tumors, radiation, bone tissue, breast cancer, skin diseases, gynecology, rhabdo, myosarcoma, whole body radiation, hyperfractionation, head neck, thymomas, mediastinal masses, cns tumors, esophagus, renal carcinoma, desmoid tumor of the abdominal wall, neuro, radiation oncology, google, comprehensive board review, devita, hellman, rosenbergs cancer, e-book, e-books, Amazon Kindle, Palm, mobipocket, pda books, PDF, Iliad, DRM-free, Palm DOC, RTF, EPUB

Medical-technology-news

The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

  • New inflammation inhibitor discovered November 15, 2018
    A multidisciplinary team of researchers have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able to reduce the signals that trigger an inflammation.
  • Drug combination makes cancer disappear in mice with neuroblastoma November 15, 2018
    Researchers investigating new treatments for neuroblastoma -- one of the most common childhood cancers -- have found that a combination of two drugs made tumors disappear in mice, making it more effective than any other drugs tested in these animals.
  • A new approach to detecting cancer earlier from blood tests November 14, 2018
    Cancer scientists have combined 'liquid biopsy,' epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
  • Rainforest vine compound starves pancreatic cancer cells November 14, 2018
    Pancreatic cancer cells are known for their ability to thrive under extreme conditions of low nutrients and oxygen, a trait known in the cancer field as 'austerity.' The cells' remarkable resistance to starvation is one reason why pancreatic cancer is so deadly. Now researchers have identified a compound from a Congolese plant that has strong […]
  • Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies November 13, 2018
    Scientists have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges. DMAbs may also provide a novel powerful platform […]
  • New methods to identify Alzheimer's drug candidates with anti-aging properties November 13, 2018
    Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.
  • 'Waltzing' nanoparticles could advance search for better drug delivery methods November 13, 2018
    Scientists paired drug-delivering nanoparticles like dance partners to reveal that molecules attach to targets on cells differently based upon their position in time. The discovery could improve methods for screening drugs for therapeutic effectiveness.

CancerGroup.com